Drug: omalizumab Quarter: 2016Q3
Total Drug/Injury Combinations: 175 Number of Pages: 9
| DRUGNAME | PT | EventCount | |
|---|---|---|---|
| Omalizumab | Laryngeal cleft | 1 | view events |
| Omalizumab | Nasal obstruction | 1 | view events |
| Omalizumab | Peripheral ischaemia | 1 | view events |
| Omalizumab | Pharyngitis streptococcal | 1 | view events |
| Omalizumab | Premature rupture of membranes | 1 | view events |
| Omalizumab | Pyoderma | 1 | view events |
| Omalizumab | Rales | 1 | view events |
| Omalizumab | Rheumatic disorder | 1 | view events |
| Omalizumab | Rhinitis | 1 | view events |
| Omalizumab | Sinusitis | 1 | view events |
| Omalizumab | Stillbirth | 1 | view events |
| Omalizumab | Synovial disorder | 1 | view events |
| OMALIZUMAB | Uterine haemorrhage | 1 | view events |
| OMALIZUMAB | Vaginal haemorrhage | 1 | view events |
| Omalizumab | Ventricular arrhythmia | 1 | view events |
Total Drug/Injury Combinations: 175 Number of Pages: 9
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)